Organisation: Arakis

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Renevo makes second attempt at floatation

The improving fortunes of the UK biotech industry were highlighted today when Renovo launched its second attempt to list on the stock market.

Mon, 27 Mar, 2006

Novartis in $375m lung treatment deal

SWISS drugmaker Novartis unveiled one of the biggest-ever deals in the European biotech sector yesterday, taking on an experimental treatment for lung disease from two British firms for up to $375 million.

Thu, 14 Apr, 2005

'Smoker's lung' drug wins firms multi-million pound deal

An inhaler treatment for “smoker’s lung” was today at the centre of one of the biggest-ever deals in the UK biotech sector.

Wed, 13 Apr, 2005

Inhaled drugs firm plans flotation

A biotechnology company which is developing an inhaled alternative to Viagra today announced plans to float on the London stock market.

Mon, 14 Jun, 2004